Marriott International Inc vs NeoGenomics Inc. Common Stock — how do they compare? Marriott International Inc trades at $374.01 (market cap $96.96B), while NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B). The key difference: Marriott International Inc is far larger — about 44.7× NeoGenomics Inc. Common Stock's market cap, and Marriott International Inc pays a 0.79% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marriott International Inc for 164 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MAR | NEO | |
|---|---|---|
Market Cap | $96.96B | $2.17B |
Volume | 1,354,129 | 1,615,943 |
Sector | Consumer Cyclical | Health |
52-Week High | $402.54 | $19.91 |
52-Week Low | $259.04 | $7.19 |
Typical Hold Time | 164 Days | 0 Days |
Enterprise Value | $114.27B | $2.47B |
Dividend Yield | 0.79% | — |
Signals from Pluang's Aura AI — not financial advice
Marriott International (MAR) trades at $371.50, up 0.6% with a bullish technical outlook. The stock shows strong profitability with 9.62% net margin and has beaten earnings estimates in two of the last three quarters. Recent developments include a new technology partnership with LG Electronics and continued institutional interest. The company maintains solid revenue growth, reaching $26.19B in 2025, though debt levels have increased to 58.83% of assets.
Marriott presents a favorable investment case with analyst consensus target of $388.93 representing 4.7% upside. The travel recovery theme supports growth, but elevated valuation multiples (P/E 38.49) and rising leverage require monitoring. Key risks include economic sensitivity and competitive pressures in the hospitality sector.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →